| Patent application number | Description | Published |
|---|
| 20090081123 | PHARMACEUTICAL COMPOUNDS - Tricyclic pyrazole derivatives of the following formula (I) having affinity for the cannabinoidergic CB1 and/or CB2 receptors: | 03-26-2009 |
| 20100028257 | PHARMACEUTICAL COMPOUNDS - Nonane and decane diazabicyclic derivatives having homopiperazine as main ring, having affinity for the opioidergic μ and/or δ and/or k receptors and/or for all their receptorial subclasses, with central and/or peripheral activity, having formula (I), the isomeric forms and their mixtures included, wherein one or more atoms are in the corresponding isotopic forms: | 02-04-2010 |
| 20100029622 | MICROEMULSIONS - Pharmaceutical compositions in the form of microemulsions comprising the following components, in amounts expressed as % by weight, the sum of the components being 100%:
| 02-04-2010 |
| 20100105896 | PHARMACEUTICAL COMPOUNDS - Pyrazole derivatives of the following formula (I), having affinity for the cannabinoidergic CB1 and/or CB2 receptors: | 04-29-2010 |
| 20100215741 | PHARMACEUTICAL COMPOUNDS - Condensed tricyclic compounds having a condensed structure containing one phenyl and one pyrazole ring linked with each other by a central ring comprising from five to eight atoms, having affinity for the CB1 and/or CB2 receptors, with central nervous system and/or peripheral activity, of formula (I): | 08-26-2010 |
| 20100215759 | PHARMACEUTICAL COMPOUNDS - Condensed tricyclic pyrazole compounds having affinity for the CB1 and/or CB2 cannabinoidergic receptors, with activity both on the peripheral and central nervous system, of formula (I): | 08-26-2010 |
| 20100216785 | PHARMACEUTICAL COMPOSITIONS - Microemulsions of pharmaceutical compositions comprising, the following components (% by weight), the sum of the components being 100%:
| 08-26-2010 |
| 20110152238 | PHARMACEUTICAL COMPOUNDS - Diazapolycyclic compounds having affinity for the opioidergic receptors, preferably for the delta opioidergic receptors, with central and/or peripheral activity, having formula: | 06-23-2011 |
